GlassScriptPhysician profile
Parrin T Barton
NPI 1093757239
$1,504.04
in general payments reported to CMS, 2019-2025
13 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $1,027 · 2021: $15.70 · 2022: $17.64 · 2023: $30.60 · 2024: $163 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $313.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $980.38 | 2020 | |
| Boston Scientific Corporation | $140.28 | 2024 | Varithena Administration Pack |
| Glaxosmithkline, LLC. | $82.85 | 2019 | |
| Exact Sciences Corporation | $70.51 | 2025 | Cologuard Collection Kit |
| Bioventus LLC | $47.53 | 2019 | |
| Fidia Pharma USA INC. | $38.47 | 2020-2024 | Triluron, Hymovis, Hyalgan |
| Tactile Systems Technology INC | $37.20 | 2022-2025 | Flexitouch Plus, Nimbl |
| Angiodynamics, INC. | $30.68 | 2020 | |
| Surgenex LLC | $17.37 | 2025 | Ardeograft, Surmatrix, Pellograft |
| Sanofi-Aventis U.S. LLC | $17.33 | 2023 | |
| Merz North America, INC. | $15.70 | 2021 | |
| Currax Pharmaceuticals LLC | $13.27 | 2023 | Contrave |
| Cequr Corporation | $12.47 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parrin Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.